Sesen Bio (SESN) Stock Jumps Amid Recent News: What Should You Know?

Yesterday, Sesen Bio shares jumped by 25.74% and traded at $1.2700. Today, in the pre-market the price has increased by 11.81% and is $1.42. Since the beginning of this month, SESN stock has made significant changes. On October 1, the stock price was $0.7703. Two weeks later, the stock jumped to $1.0511. Sesen Bio is a late-stage clinical firm specializing in the design, engineering, development, and commercialization of targeted fusion protein therapies (TFPTs) for the treatment of cancer patients. Sesen Bio (SESN) has been granted a Type A meeting with the FDA to discuss the Chemistry, Manufacturing, and Controls (CMC) problems mentioned in Vicineum’s Complete Response Letter for BCG-Immune Non-muscle Invasive Bladder Cancer. On October 29, the CMC Type A meeting will take place. The corporation is also planning for a Type A meeting to address suggestions regarding the CRL’s additional data and findings. The Type A Clinical Meeting is expected to take place in the fourth quarter of 2021, according to the business.

Lora Nilsson

Finance and Business reporterAfter graduating high school. Lora decided to travel and blog as a part-timer. Today she enjoys what she loves and works remotely as our finance and business reporter